MP:0001634 | internal hemorrhage | "blood loss in the interior of the body due to vessel rupture or dysmorphology " [J:23170] |
Show
Allelic Composition: Rb1tm2Brn/Rb1tm2Brn,Trp53tm1Brd/Trp53+,Tg(Rbp3-cre)1Brn/0 Genetic Background: involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N
|
MP:0002412 | increased susceptibility to bacterial infection | "greater likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129S2-Vwftm1Wgr
|
MP:0002551 | abnormal blood coagulation | "altered ability or inability of the blood to clot" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Rb1tm2Brn/Rb1tm2Brn,Trp53tm1Brd/Trp53+,Tg(Rbp3-cre)1Brn/0 Genetic Background: involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N
Allelic Composition: Vwftm1Wgr/Vwf+ Genetic Background: involves: 129S2/SvPas * C57BL/6J
Allelic Composition: Fgatm1Jld/Fgatm1Jld,Vwftm1Wgr/Vwftm1Wgr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6J
Allelic Composition: Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129S2-Vwftm1Wgr
Allelic Composition: Adamts13tm1Dgi/Adamts13tm1Dgi,Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129-Adamts13tm1Dgi Vwftm1Wgr
|
MP:0003038 | decreased infarction size | "decreased size of necrotic area from normal of the myocardium resulting from a sudden insufficiency of arterial or venous blood supply due to emboli, thrombi or mechanical factors" [MeSH:National Library of Medicine - Medical Subject Headings, 2003, Stedman s Medical Dictionary, 27th edition:ISBN 0-683-40008-8, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Adamts13tm1Dgi/Adamts13tm1Dgi,Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129-Adamts13tm1Dgi Vwftm1Wgr
|
MP:0003292 | melena | "dark colored, foul-smelling feces due to the presence of blood" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, ncbi:Matthew Mailman, NCBI request] |
Show
Allelic Composition: Rb1tm2Brn/Rb1tm2Brn,Trp53tm1Brd/Trp53+,Tg(Rbp3-cre)1Brn/0 Genetic Background: involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N
|
MP:0004720 | abnormal platelet morphology | "any structural anomaly of blood plasma cells derived from megakaryocytes, which function to promote blood clotting" [MESH:National Library of Medicine_Medical Subject Headings] |
Show
Allelic Composition: Gria2tm1Rod/Gria2+ Genetic Background: B6.129-Gria2tm1Rod/J
|
MP:0004799 | increased susceptibility to experimental autoimmune encephalomyelitis | "greater likelihood that an organism will develop disease symptoms similar to human multiple sclerosis upon induction with antigens to Myelin Basic Protein (MBP), Proteolipid Protein (PLP), and/or Myelin Oligodendrocyte glycoprotein (MOG)" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129S2-Vwftm1Wgr
|
MP:0005167 | abnormal blood-brain barrier | "anomaly in the structure or function of the group of barriers and transport systems in the brain capillary endothelium that controls the entrance of substances into the brain extracellular space from the blood" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129S2-Vwftm1Wgr
|
MP:0005341 | decreased susceptibility to atherosclerosis | "less likely than the norm to develop thickening and loss of elasticity of arterial walls, involving lipid deposition and thickening of intimal layers within arteries" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Ldlrtm1Her/Ldlrtm1Her,Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129S-Vwftm1Wgr Ldlrtm1Her
|
MP:0005464 | abnormal platelet physiology | "atypical response of the non-nucleated cells found in the blood and involved in blood coagulation" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Rb1tm2Brn/Rb1tm2Brn,Trp53tm1Brd/Trp53+,Tg(Rbp3-cre)1Brn/0 Genetic Background: involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N
|
MP:0005606 | increased bleeding time | "greater than the normal duration of blood flow after skin puncture; indicative of platelet and capillary function" [MeSH:National Library of Medicine - Medical Subject Headings , 2003, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Rb1tm2Brn/Rb1tm2Brn,Trp53tm1Brd/Trp53+,Tg(Rbp3-cre)1Brn/0 Genetic Background: involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N
Allelic Composition: Vwftm1.1Diac/Vwftm1.1Diac Genetic Background: Not Specified
Allelic Composition: Vwftm2.1Diac/Vwftm2.1Diac Genetic Background: Not Specified
Allelic Composition: Vwftm3.1(VWF)Diac/Vwftm3.1(VWF)Diac Genetic Background: Not Specified
|
MP:0006059 | decreased susceptibility to ischemic brain injury | "decreased lesion size following loss of circulation in a region of the brain; may be induced or spontaneous" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Adamts13tm1Dgi/Adamts13tm1Dgi,Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129-Adamts13tm1Dgi Vwftm1Wgr
|
MP:0006298 | abnormal platelet activation | "anomaly in the series of progressive, overlapping events triggered by exposure of platelets to signals from subendothelial tissue, including shape change, adhesiveness, aggregation, and release reactions; when carried through to completion, these events lead to the formation of a stable hemostatic plug" [GO:0030168, MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Vwftm1.1Diac/Vwftm1.1Diac Genetic Background: Not Specified
|
MP:0008874 | decreased sensitivity to xenobiotics | "increase in the dose or concentration of a foreign compound required to induce a specific level of response" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gria2tm1Rod/Gria2+ Genetic Background: B6.129-Gria2tm1Rod/J
|
MP:0009767 | decreased sensitivity to xenobiotic induced morbidity/mortality | "increase in the amount of a foreign compound required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gria2tm1Rod/Gria2+ Genetic Background: B6.129-Gria2tm1Rod/J
|
MP:0011086 | partial postnatal lethality | "the appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms anytime between the neonatal period and weaning age (Mus: P1 to approximately 3 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Fgatm1Jld/Fgatm1Jld,Vwftm1Wgr/Vwftm1Wgr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6J
|
MP:0020215 | impaired blood coagulation | "impaired ability of the blood to clot" [GOC:NV] |
Show
Allelic Composition: Vwftm1.1Diac/Vwftm1.1Diac Genetic Background: Not Specified
Allelic Composition: Vwftm2.1Diac/Vwftm2.1Diac Genetic Background: Not Specified
Allelic Composition: Vwftm3.1(VWF)Diac/Vwftm3.1(VWF)Diac Genetic Background: Not Specified
|
MP:0020332 | impaired leukocyte tethering or rolling | "reduced ability or inability in the transient adhesive interactions between leukocytes and endothelial cells lining blood vessels mediated primarily by selectins and which are typically the first step in cellular extravasation" [GO:0050901, ORCID: orcid.org/0000-0003-4606-0597] |
Show
Allelic Composition: Ldlrtm1Her/Ldlrtm1Her,Vwftm1Wgr/Vwftm1Wgr Genetic Background: B6.129S-Vwftm1Wgr Ldlrtm1Her
|